Patient, Provider Type, and Procedure Type Factors Associated with Opioid Prescribing by Dentists in a Health Care System

D Brad Rindal, Stephen E Asche, Sheryl Kane, Anjali R Truitt, Donald C Worley, Lauryn M Davin, Jan Gryczynski, Shannon G Mitchell, D Brad Rindal, Stephen E Asche, Sheryl Kane, Anjali R Truitt, Donald C Worley, Lauryn M Davin, Jan Gryczynski, Shannon G Mitchell

Abstract

Introduction: Reports examining opioid prescribing for dental conditions are limited and do not examine patient-level factors. This study examines the association of patient age, sex, race, ethnicity, Medicaid coverage, and the need for an interpreter in addition to procedure type and dental provider type with receipt of an opioid prescription in dental care settings within a large health system.

Materials and methods: This study was conducted utilizing data from the electronic health record of HealthPartners, a large dental practice embedded within a health care system. The analytic sample consisted of all 169,173 encounters from 90,487 patients undergoing a dental procedure in the baseline period (9/1/2018 to 8/30/2019), prior to implementing a clinical trial to de-implement opioids in dentistry.

Results: Opioids were prescribed at 1.9% of all 169,173 encounters and rates varied by patient factors, procedure category, and provider type. Opioid prescriptions were most likely for extraction encounters (25.9%). In a multivariable analysis of 8760 extraction encounters, all patient age groups were more likely than those age 66+ to receive an opioid prescription, particularly those age 18-25 (OR=6.94). Patients having a complex rather than simple extraction were more likely to receive an opioid prescription (OR=6.31) and those seen by an oral surgeon rather than a general dentist (OR=9.11) were more likely to receive an opioid prescription. Among 108,748 encounters with a diagnostic procedure, opioid prescribing was more likely among male than female patients (OR=1.20), Black patients relative to White (OR=1.69), patients with Medicaid coverage (OR=1.86), and patients seeing an oral surgeon rather than a general dentist (OR=27.81).

Conclusion: Opioid prescribing rates vary considerably depending on procedure type. Patterns of associations between patient factors and opioid prescribing also vary considerably across procedure type. To understand which patient groups are more at risk of being prescribed opioids, it is essential to consider the procedures they are receiving.

Keywords: analgesics; dentistry; opioid; oral surgical procedures; practice patterns; prescribing.

Conflict of interest statement

Unrelated to the present study, Dr. Gryczynski has received research funding from Indivior (paid to his institution and including project-related salary support) and is part of the owner of COG Analytics; and grants from NIH/NIDA, outside the submitted work. Mr Stephen E Asche reports grants from NIDCR, during the conduct of the study. No other authors have any competing interests.

© 2021 Rindal et al.

Figures

Figure 1
Figure 1
Analytic sample and distribution of patient encounter in procedure categories.

References

    1. United States Government Accountability Office (GAO). Prescription Pain Reliever Abuse; 2011.
    1. Centers for Disease Control and Prevention (CDC). Unintentional Drug Poisoning in the United States; 2010.
    1. Center for Disease Control and Prevention (CDC). Opioid overdose what can you do to prevent opioid overdose deaths?; 2020. Available from: . Accessed April 24, 2020.
    1. Volkow ND, McLellan AT. Opioid abuse in chronic pain–misconceptions and mitigation strategies. N Engl J Med. 2016;374(13):1253–1263. doi:10.1056/NEJMra1507771
    1. Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths - United States, 2010–2015. MMWR Morb Mortal Wkly Rep. 2016;65(5051):1445–1452. doi:10.15585/mmwr.mm655051e1
    1. Rummans TA, Burton MC, Dawson NL. How good intentions contributed to bad outcomes: the opioid crisis. Mayo Clin Proc. 2018;93(3):344–350. doi:10.1016/j.mayocp.2017.12.020
    1. U.S. Department of Health and Human Services (DHHS), Behavioral Health Coordinating Committee, Prescription Drug Abuse Subcommittee. Addressing Prescription Drug Abuse in the United States Current Activities and Future Opportunities. Washington, DC; 2014.
    1. Moore PA, Nahouraii HS, Zovko JG, Wisniewski SR. Dental therapeutic practice patterns in the U.S. II. Analgesics, corticosteroids, and antibiotics. Gen Dent. 2006;54(3):201–207;quiz 208, 221–202.
    1. Volkow ND, McLellan TA, Cotto JH, Karithanom M, Weiss SR. Characteristics of opioid prescriptions in 2009. JAMA. 2011;305(13):1299–1301. doi:10.1001/jama.2011.401
    1. Levy B, Paulozzi L, Mack KA, Jones CM. Trends in opioid analgesic-prescribing rates by specialty, U.S., 2007–2012. Am J Prev Med. 2015;49(3):409–413. doi:10.1016/j.amepre.2015.02.020
    1. Gupta N, Vujicic M, Blatz A. Multiple opioid prescriptions among privately insured dental patients in the United States: evidence from claims data. J Am Dent Assoc. 2018;149(7):619–627.e611. doi:10.1016/j.adaj.2018.02.025
    1. Friedman JW. The prophylactic extraction of third molars: a public health hazard. Am J Public Health. 2007;97(9):1554–1559. doi:10.2105/AJPH.2006.100271
    1. Pogrel MA, Dodson TB, Swift JQ, et al. White paper on third molar data. American Association of Oral and Maxillofacial Surgeons; 2007:1–25.
    1. Schroeder AR, Dehghan M, Newman TB, Bentley JP, Park KT. Association of opioid prescriptions from dental clinicians for US adolescents and young adults with subsequent opioid use and abuse. JAMA Intern Med. 2019;179(2):145–152. doi:10.1001/jamainternmed.2018.5419
    1. Steinmetz CN, Zheng C, Okunseri E, Szabo A, Okunseri C. Opioid analgesic prescribing practices of dental professionals in the United States. JDR Clin Trans Res. 2017;2(3):241–248.
    1. Sabounchi SS, Sabounchi SS, Cosler LE, Atav AS. Opioid prescribing and misuse among dental patients in the US: a literature-based review. Quintessence Int. 2020;51(1):64–76.
    1. Friedman J, Kim D, Schneberk T, et al. Assessment of racial/ethnic and income disparities in the prescription of opioids and other controlled medications in California. JAMA Intern Med. 2019;179(4):469–476. doi:10.1001/jamainternmed.2018.6721
    1. Ringwalt C, Roberts AW, Gugelmann H, Skinner AC. Racial disparities across provider specialties in opioid prescriptions dispensed to Medicaid beneficiaries with chronic noncancer pain. Pain Med. 2015;16(4):633–640. doi:10.1111/pme.12555
    1. Singhal A, Tien YY, Hsia RY. Racial-ethnic disparities in opioid prescriptions at emergency department visits for conditions commonly associated with prescription drug abuse. PLoS One. 2016;11(8):e0159224. doi:10.1371/journal.pone.0159224
    1. Lutfiyya MN, Gross AJ, Schvaneveldt N, Woo A, Lipsky MS. A scoping review exploring the opioid prescribing practices of US dental professionals. J Am Dent Assoc. 2018;149(12):1011–1023. doi:10.1016/j.adaj.2018.07.017
    1. Nadeau R, Hasstedt K, Sunstrum AB, Wagner C, Tu H. Addressing the opioid epidemic: impact of opioid prescribing protocol at the University of Minnesota School of Dentistry. Craniomaxillofac Trauma Reconstr. 2018;11(2):104–110. doi:10.1055/s-0038-1649498
    1. Helping to End Addiction Long-Term (HEAL) Initiative. NCT03584789: National Institute of Dental & Craniofacial Research (NIDCR). Available from: . Accessed October 4, 2021.
    1. Rindal DB, Asche SE, Gryczynski J, et al. De-Implementing Opioid Use and Implementing Optimal Pain Management Following Dental Extractions (DIODE): protocol for a cluster randomized trial. JMIR Res Protoc. 2021;10(4):e24342. doi:10.2196/24342
    1. Webster LR. Risk factors for opioid-use disorder and overdose. Anesth Analg. 2017;125(5):1741–1748. doi:10.1213/ANE.0000000000002496
    1. Naji L, Dennis BB, Bawor M, et al. The association between age of onset of opioid use and comorbidity among opioid dependent patients receiving methadone maintenance therapy. Addict Sci Clin Pract. 2017;12(1):9. doi:10.1186/s13722-017-0074-0
    1. Janakiram C, Chalmers NI, Fontelo P, et al. Sex and race or ethnicity disparities in opioid prescriptions for dental diagnoses among patients receiving Medicaid. J Am Dent Assoc. 2019;150(10):e135–e144. doi:10.1016/j.adaj.2019.06.016
    1. American Dental Association (ADA). Frequently asked questions for opioid prescribing; 2018. Available from: . Accessed September 22, 2021.
    1. Center for Disease Control and Prevention (CDC). Postsurgical Pain; 2020. Available from: . Accessed September 22, 2021.
    1. Miech R, Johnston L, O’Malley PM, Keyes KM, Heard K. Prescription opioids in adolescence and future opioid misuse. Pediatrics. 2015;136(5):e1169–1177. doi:10.1542/peds.2015-1364
    1. Moore RA, Wiffen PJ, Derry S, Maguire T, Roy YM, Tyrrell L. Non-prescription (OTC) oral analgesics for acute pain - an overview of Cochrane reviews. Cochrane Database Syst Rev. 2015;(11):CD010794. doi:10.1002/14651858.CD010794.pub2
    1. Moore PA, Ziegler KM, Lipman RD, Aminoshariae A, Carrasco-Labra A, Mariotti A. Benefits and harms associated with analgesic medications used in the management of acute dental pain: an overview of systematic reviews. J Am Dent Assoc. 2018;149(4):256–265. doi:10.1016/j.adaj.2018.02.012
    1. Thornhill MH, Suda KJ, Durkin MJ, Lockhart PB. Is it time US dentistry ended its opioid dependence? J Am Dent Assoc. 2019;150(10):883–889. doi:10.1016/j.adaj.2019.07.003

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner